Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome

Claire S. Philipp, Ambarina S. Faiz, Michele G. Beckman, Althea Grant, Paula L. Bockenstedt, John A. Heit, Andra H. James, Roshni Kulkarni, Marilyn J. Manco-Johnson, Stephan Moll, Thomas L. Ortel

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Introduction Black women have an increased risk of adverse pregnancy outcomes and the characteristics of thrombotic risk factors in this population are unknown. The objective of this study was to examine the racial differences in thrombotic risk factors among women with adverse pregnancy outcomes. Methods Uniform data were collected in women with adverse pregnancy outcomes (pregnancy losses, intrauterine growth restriction (IUGR), prematurity, placental abruption and preeclampsia) referred to Thrombosis Network Centers funded by the Centers for Disease Control and Prevention (CDC). Results Among 343 white and 66 black women seen for adverse pregnancy outcomes, protein S and antithrombin deficiencies were more common in black women. The prevalence of diagnosed thrombophilia was higher among whites compared to blacks largely due to Factor V Leiden mutation. The prevalence of a personal history of venous thromboembolism (VTE) did not differ significantly by race. A family history of VTE, thrombophilia, and stroke or myocardial infarction (MI) was higher among whites. Black women had a higher body mass index, and a higher prevalence of hypertension, while the prevalence of sickle cell disease was approximately 27 fold higher compared to the general US black population. Conclusions Thrombotic risk factors differ significantly in white and black women with adverse pregnancy outcomes. Such differences highlight the importance of considering race separately when assessing thrombotic risk factors for adverse pregnancy outcomes.

Original languageEnglish (US)
Pages (from-to)108-111
Number of pages4
JournalThrombosis Research
Volume133
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Pregnancy Outcome
Thrombophilia
Venous Thromboembolism
Protein S Deficiency
Pregnancy Proteins
Abruptio Placentae
Antithrombins
Sickle Cell Anemia
Centers for Disease Control and Prevention (U.S.)
Pre-Eclampsia
hydroquinone
Population
Body Mass Index
Thrombosis
Stroke
Myocardial Infarction
Hypertension
Pregnancy
Mutation
Growth

Keywords

  • adverse pregnancy outcomes
  • racial disparities
  • thrombophilia
  • Thrombotic risk factors

ASJC Scopus subject areas

  • Hematology

Cite this

Philipp, C. S., Faiz, A. S., Beckman, M. G., Grant, A., Bockenstedt, P. L., Heit, J. A., ... Ortel, T. L. (2014). Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome. Thrombosis Research, 133(1), 108-111. https://doi.org/10.1016/j.thromres.2013.10.035

Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome. / Philipp, Claire S.; Faiz, Ambarina S.; Beckman, Michele G.; Grant, Althea; Bockenstedt, Paula L.; Heit, John A.; James, Andra H.; Kulkarni, Roshni; Manco-Johnson, Marilyn J.; Moll, Stephan; Ortel, Thomas L.

In: Thrombosis Research, Vol. 133, No. 1, 01.2014, p. 108-111.

Research output: Contribution to journalArticle

Philipp, CS, Faiz, AS, Beckman, MG, Grant, A, Bockenstedt, PL, Heit, JA, James, AH, Kulkarni, R, Manco-Johnson, MJ, Moll, S & Ortel, TL 2014, 'Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome', Thrombosis Research, vol. 133, no. 1, pp. 108-111. https://doi.org/10.1016/j.thromres.2013.10.035
Philipp, Claire S. ; Faiz, Ambarina S. ; Beckman, Michele G. ; Grant, Althea ; Bockenstedt, Paula L. ; Heit, John A. ; James, Andra H. ; Kulkarni, Roshni ; Manco-Johnson, Marilyn J. ; Moll, Stephan ; Ortel, Thomas L. / Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome. In: Thrombosis Research. 2014 ; Vol. 133, No. 1. pp. 108-111.
@article{d00308c1b8b74edd850d0149d4745555,
title = "Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome",
abstract = "Introduction Black women have an increased risk of adverse pregnancy outcomes and the characteristics of thrombotic risk factors in this population are unknown. The objective of this study was to examine the racial differences in thrombotic risk factors among women with adverse pregnancy outcomes. Methods Uniform data were collected in women with adverse pregnancy outcomes (pregnancy losses, intrauterine growth restriction (IUGR), prematurity, placental abruption and preeclampsia) referred to Thrombosis Network Centers funded by the Centers for Disease Control and Prevention (CDC). Results Among 343 white and 66 black women seen for adverse pregnancy outcomes, protein S and antithrombin deficiencies were more common in black women. The prevalence of diagnosed thrombophilia was higher among whites compared to blacks largely due to Factor V Leiden mutation. The prevalence of a personal history of venous thromboembolism (VTE) did not differ significantly by race. A family history of VTE, thrombophilia, and stroke or myocardial infarction (MI) was higher among whites. Black women had a higher body mass index, and a higher prevalence of hypertension, while the prevalence of sickle cell disease was approximately 27 fold higher compared to the general US black population. Conclusions Thrombotic risk factors differ significantly in white and black women with adverse pregnancy outcomes. Such differences highlight the importance of considering race separately when assessing thrombotic risk factors for adverse pregnancy outcomes.",
keywords = "adverse pregnancy outcomes, racial disparities, thrombophilia, Thrombotic risk factors",
author = "Philipp, {Claire S.} and Faiz, {Ambarina S.} and Beckman, {Michele G.} and Althea Grant and Bockenstedt, {Paula L.} and Heit, {John A.} and James, {Andra H.} and Roshni Kulkarni and Manco-Johnson, {Marilyn J.} and Stephan Moll and Ortel, {Thomas L.}",
year = "2014",
month = "1",
doi = "10.1016/j.thromres.2013.10.035",
language = "English (US)",
volume = "133",
pages = "108--111",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome

AU - Philipp, Claire S.

AU - Faiz, Ambarina S.

AU - Beckman, Michele G.

AU - Grant, Althea

AU - Bockenstedt, Paula L.

AU - Heit, John A.

AU - James, Andra H.

AU - Kulkarni, Roshni

AU - Manco-Johnson, Marilyn J.

AU - Moll, Stephan

AU - Ortel, Thomas L.

PY - 2014/1

Y1 - 2014/1

N2 - Introduction Black women have an increased risk of adverse pregnancy outcomes and the characteristics of thrombotic risk factors in this population are unknown. The objective of this study was to examine the racial differences in thrombotic risk factors among women with adverse pregnancy outcomes. Methods Uniform data were collected in women with adverse pregnancy outcomes (pregnancy losses, intrauterine growth restriction (IUGR), prematurity, placental abruption and preeclampsia) referred to Thrombosis Network Centers funded by the Centers for Disease Control and Prevention (CDC). Results Among 343 white and 66 black women seen for adverse pregnancy outcomes, protein S and antithrombin deficiencies were more common in black women. The prevalence of diagnosed thrombophilia was higher among whites compared to blacks largely due to Factor V Leiden mutation. The prevalence of a personal history of venous thromboembolism (VTE) did not differ significantly by race. A family history of VTE, thrombophilia, and stroke or myocardial infarction (MI) was higher among whites. Black women had a higher body mass index, and a higher prevalence of hypertension, while the prevalence of sickle cell disease was approximately 27 fold higher compared to the general US black population. Conclusions Thrombotic risk factors differ significantly in white and black women with adverse pregnancy outcomes. Such differences highlight the importance of considering race separately when assessing thrombotic risk factors for adverse pregnancy outcomes.

AB - Introduction Black women have an increased risk of adverse pregnancy outcomes and the characteristics of thrombotic risk factors in this population are unknown. The objective of this study was to examine the racial differences in thrombotic risk factors among women with adverse pregnancy outcomes. Methods Uniform data were collected in women with adverse pregnancy outcomes (pregnancy losses, intrauterine growth restriction (IUGR), prematurity, placental abruption and preeclampsia) referred to Thrombosis Network Centers funded by the Centers for Disease Control and Prevention (CDC). Results Among 343 white and 66 black women seen for adverse pregnancy outcomes, protein S and antithrombin deficiencies were more common in black women. The prevalence of diagnosed thrombophilia was higher among whites compared to blacks largely due to Factor V Leiden mutation. The prevalence of a personal history of venous thromboembolism (VTE) did not differ significantly by race. A family history of VTE, thrombophilia, and stroke or myocardial infarction (MI) was higher among whites. Black women had a higher body mass index, and a higher prevalence of hypertension, while the prevalence of sickle cell disease was approximately 27 fold higher compared to the general US black population. Conclusions Thrombotic risk factors differ significantly in white and black women with adverse pregnancy outcomes. Such differences highlight the importance of considering race separately when assessing thrombotic risk factors for adverse pregnancy outcomes.

KW - adverse pregnancy outcomes

KW - racial disparities

KW - thrombophilia

KW - Thrombotic risk factors

UR - http://www.scopus.com/inward/record.url?scp=84890552137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890552137&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2013.10.035

DO - 10.1016/j.thromres.2013.10.035

M3 - Article

C2 - 24246297

AN - SCOPUS:84890552137

VL - 133

SP - 108

EP - 111

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 1

ER -